Exosomal MALAT1 Derived from High Glucose-Treated Macrophages Up-Regulates Resistin Expression via miR-150-5p Downregulation

Int J Mol Sci. 2022 Jan 20;23(3):1095. doi: 10.3390/ijms23031095.

Abstract

Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) plays a crucial role in the pathophysiological process associated with diabetes-related complications. The effect of high glucose levels on macrophage-derived exosomal MALAT1 is unknown. Therefore, we investigated the molecular regulatory mechanisms controlling exosomal MALAT1 in macrophages under high glucose treatment and the therapeutic target of macrophage-derived exosomal MALAT1 using a balloon injury model of vascular disease in diabetic rats. High glucose (25 mM) significantly increased MALAT1 expression in macrophage-derived exosomes. MALAT1 suppressed miR-150-5p expression in macrophage-derived exosomes under high-glucose conditions. Silencing MALAT1 using MALAT1 siRNA significantly reversed miR-150-5p expression induced by macrophage-derived exosomes. Macrophage-derived exosomes under high-glucose treatment significantly increased resistin expression in macrophages. Silencing MALAT1 and overexpression of miR-150-5p significantly decreased resistin expression induced by macrophage-derived exosomes. Overexpression of miR-150-5p significantly decreased resistin luciferase activity induced by macrophage-derived exosomes. Macrophage-derived exosome significantly decreased glucose uptake in macrophages and silencing MALAT1, resistin or overexpression of miR-150-5p significantly reversed glucose uptake. Balloon injury to the carotid artery significantly increased MALAT1 and resistin expression and significantly decreased miR-150-5p expression in arterial tissue. Silencing MALAT1 significantly reversed miR-150-5p expression in arterial tissue after balloon injury. Silencing MALAT1 or overexpression of miR-150-5p significantly reduced resistin expression after balloon injury. In conclusion, high glucose up-regulates MALAT1 to suppress miR-150-5p expression and counteracts the inhibitory effect of miR-150-5p on resistin expression in macrophages to promote vascular disease. Macrophage-derived exosomes containing MALAT1 may serve as a novel cell-free approach for the treatment of vascular disease in diabetes mellitus.

Keywords: MALAT1; exosome; high glucose; macrophage; miR-1505p; resistin.

MeSH terms

  • Animals
  • Carotid Artery Diseases / etiology
  • Carotid Artery Diseases / metabolism
  • Carotid Artery Diseases / pathology*
  • Diabetes Mellitus, Experimental / complications*
  • Disease Models, Animal
  • Exosomes / genetics
  • Exosomes / metabolism
  • Gene Expression Regulation
  • Glucose / toxicity*
  • Hyperglycemia / chemically induced
  • Hyperglycemia / pathology*
  • Macrophages / metabolism
  • Macrophages / pathology
  • Male
  • Mice
  • MicroRNAs / antagonists & inhibitors*
  • RNA, Long Noncoding / genetics
  • RNA, Long Noncoding / metabolism*
  • Rats
  • Rats, Wistar
  • Resistin / genetics
  • Resistin / metabolism*
  • Sweetening Agents / toxicity

Substances

  • Malat1 long non-coding RNA, mouse
  • MicroRNAs
  • Mirn150 microRNA, mouse
  • RNA, Long Noncoding
  • Resistin
  • Sweetening Agents
  • Glucose